Results

Repare Therapeutics Inc.

03/30/2021 | Press release | Distributed by Public on 03/30/2021 14:28

Repare Therapeutics to Introduce RP-6306, a Potent and Specific Inhibitor of a Novel Target, at Virtual Investor Day on April 8